Discipline | Pharmaceutical science |
---|---|
Language | English |
Edited by | John M. Pezzuto |
Publication details | |
History | 1961-present |
Publisher | |
Frequency | Monthly |
2.971 (2019) | |
Standard abbreviations | |
ISO 4 | Pharm. Biol. |
Indexing | |
CODEN | PHBIFC |
ISSN | 1388-0209 (print) 1744-5116 (web) |
LCCN | sn98030858 |
OCLC no. | 637673973 |
Links | |
Pharmaceutical Biology is a monthly peer-reviewed medical journal that publishes research on natural product research related to pharmaceutical biology. The editor-in-chief is John M. Pezzuto (Western New England University).
Pharmacology is the science of drugs and medications, including a substance's origin, composition, pharmacokinetics, pharmacodynamics, therapeutic use, and toxicology. More specifically, it is the study of the interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function. If substances have medicinal properties, they are considered pharmaceuticals.
Biochemists are scientists who are trained in biochemistry. They study chemical processes and chemical transformations in living organisms. Biochemists study DNA, proteins and cell parts. The word "biochemist" is a portmanteau of "biological chemist."
A Doctor of Pharmacy is a professional doctorate in pharmacy. In some countries, it is a proficient graduate degree to practice the profession of pharmacy or to become a clinical pharmacist. In many countries, people with their Doctor of Pharmacy are allowed to practice independently and can prescribe drugs directly to patients. A PharmD program has significant experiential and/or clinical education components in introductory and advanced levels for the safe and effective use of drugs. Experiential education prepares graduates to be practice-ready, as they already have spent a significant amount of time training in areas of direct patient care and research.
Medicinal or pharmaceutical chemistry is a scientific discipline at the intersection of chemistry and pharmacy involved with designing and developing pharmaceutical drugs. Medicinal chemistry involves the identification, synthesis and development of new chemical entities suitable for therapeutic use. It also includes the study of existing drugs, their biological properties, and their quantitative structure-activity relationships (QSAR).
A biological target is anything within a living organism to which some other entity is directed and/or binds, resulting in a change in its behavior or function. Examples of common classes of biological targets are proteins and nucleic acids. The definition is context-dependent, and can refer to the biological target of a pharmacologically active drug compound, the receptor target of a hormone, or some other target of an external stimulus. Biological targets are most commonly proteins such as enzymes, ion channels, and receptors.
Alagappa College of Technology is an educational institution located in Chennai, Tamil Nadu, India that offers higher education in engineering, technology and allied sciences. The college was established in 1944 and was integrated with Anna University in 1978 from University of Madras as a constituent part of Anna University within its Guindy Campus.
Medical research, also known as health research, refers to the process of using scientific methods with the aim to produce knowledge about human diseases, the prevention and treatment of illness, and the promotion of health.
Astex Pharmaceuticals is a biotechnology company focused on the discovery and development of drugs in oncology and diseases of the central nervous system. Astex was founded in 1999 by Sir Tom Blundell, Chris Abell & Harren Jhoti, and is located in Cambridge, England.
Monash University, Parkville campus is a campus of Monash University, located in Parkville, Victoria, Australia. It is home to the Faculty of Pharmacy and Pharmaceutical Sciences. Founded in 1881 and previously known as the Victorian College of Pharmacy, the faculty is the oldest school of pharmacy in Australia. A major centre of research and teaching, it is internationally regarded for its research in drug target biology and discovery, medicinal chemistry, drug development, formulation science, and medicine use and safety, including the discovery and development of the world's first successful anti-influenza drug, Relenza. In international rankings, it is ranked as the number one school of pharmacy and pharmacology in Australia and number two worldwide.
The National Academy of Sciences of the Republic of Armenia is the Armenian national academy, functioning as the primary body that conducts research and coordinates activities in the fields of science and social sciences in Armenia. It is a member of the International Science Council.
Central Drug Research Institute is a multidisciplinary research laboratory in Lucknow, India, employing scientific personnel from various areas of biomedical sciences.
Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) is part of Johnson & Johnson Innovative Medicine business segment. It is responsible for discovering and developing pharmaceutical drugs. J&JPRD has research sites located in Raritan, New Jersey, Titusville, New Jersey, Spring House, Pennsylvania, La Jolla, California, Beerse, Belgium and Toledo, Spain.
Medicon Valley is a leading international life-sciences cluster in Europe, spanning the Øresund Region of eastern Denmark and southern Sweden. It is one of Europe's strongest life science clusters, with many life science companies and research institutions located within a relatively small geographical area. The name has officially been in use since 1997.
China Pharmaceutical University is a public university in Nanjing, Jiangsu, China. It is affiliated with the Ministry of Education, and co-sponsored by the Ministry of Education and the Province of Jiangsu. It was founded in 1968 through mergers between the National College of Pharmacy and other smaller universities. The university is part of Project 211 and the Double First-Class Construction.
Allied Academies is a reportedly fraudulent corporation chartered under the laws of North Carolina. Its postal address is in London, United Kingdom. It presents itself as an association of scholars, with supporting and encouraging research and the sharing and exchange of knowledge as its stated aims. The organization consists of 30 affiliate academies, which provide awards to academics and publish academic journals both online and in hard copy for members. Since 2015 the organization has been listed on Jeffrey Beall's list of "potential, possible, or probable predatory scholarly open-access publishers". It is in a partnership with OMICS Publishing Group which uses its website and logo. In 2018, OMICS owner Srinubabu Gedela declared that he had informed the Nevada court that Allied Academies was a subsidiary of OMICS International. During a conference in 2018, they falsely listed a prominent chemist among its organizing committee who had not agreed to this and was not affiliated with Allied Academies.
Molecular Pharmaceutics is a peer-reviewed scientific journal covering research on the molecular mechanistic understanding of drug delivery and drug delivery systems, including physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science.
A geneticist is a biologist or physician who studies genetics, the science of genes, heredity, and variation of organisms. A geneticist can be employed as a scientist or a lecturer. Geneticists may perform general research on genetic processes or develop genetic technologies to aid in the pharmaceutical or and agriculture industries. Some geneticists perform experiments in model organisms such as Drosophila, C. elegans, zebrafish, rodents or humans and analyze data to interpret the inheritance of biological traits. A basic science geneticist is a scientist who usually has earned a PhD in genetics and undertakes research and/or lectures in the field. A medical geneticist is a physician who has been trained in medical genetics as a specialization and evaluates, diagnoses, and manages patients with hereditary conditions or congenital malformations; and provides genetic risk calculations and mutation analysis.
Proxalutamide is a nonsteroidal antiandrogen (NSAA) – specifically, a selective high-affinity silent antagonist of the androgen receptor (AR) – which is under development by Suzhou Kintor Pharmaceuticals, inc., a subsidiary of Kintor Pharmaceutical Limited, for the potential treatment of COVID-19, prostate cancer, and breast cancer. It was approved in Paraguay for the treatment of COVID-19 in July 2021, but has not been approved at this time in other countries.